[Rapid viral response during treatment of chronic hepatitis B with pegylated interferon alfa-2a in children--preliminary report].
The aim of the study was to assess the viral response after 4 weeks of treatment with pegylated interferon alfa-2a chronic hepatitis B. Investigations were performed in 13 children in the age 11-17 years, with CHB, treated with PegIFN alfa-2a in the dose 100mcg/m2/week. After 4 weeks treatment statistically significant decrease of HBV viral load was observed. HBV DNA dissapearance was observed in 6/13 children with lower baseline ALT activity and lower HBV viral load before treatment. HBV DNA dissapearance was revealed in naïve children with anti-HBe serum presence. During treatment no adverse events following dosis modifications were observed. Our preliminary observations of early HBV viral load supression seem to reveal that peginterferon alfa-2a may be benefit therapeutic option for children with CHB.